Federal contractor · public award history
RAFA LABORATORIES LTD
Parent: RAFA LABORATORIES LTD Unique Entity Identifier (UEI)CKDNTKNDPMJ6
- Awards we know about
- 3
- Typical size
- $11.77M
- Middle of their public awards
- Dollars on those awards
- $42.08M
Most of their awards we can see fall roughly between $10.57M and $16.36M.
SAM.gov registration
- Status
- Active
- Purpose of registration
- All awards (Z2)
- Registration expires
- Apr 26, 2027
- Activation date
- Apr 26, 2026
- Primary NAICS (SAM)
- Pharmaceutical Preparation Manufacturing325412
Other NAICS on file
Product and Service Codes (SAM)
Business types (SAM)
Registration fields from the official SAM.gov public entity extract (monthly bulk). Not a substitute for live SAM checks.
Continue contractor research
Use the verified identifiers and public award record to investigate documented incumbents, compare competitors, or identify possible teaming partners. This is a research starting point, not a capability or partner recommendation.
These official USAspending contract records do not rate capability or past performance and do not tell you whether to team or bid.
Awarding agencies
- Department of Health and Human Services (3)
Industries & product codes
Award history
- Department of Health and Human Services$11.77MSep 30, 2025Procurement Instrument Identifier (PIID)75A50125C00018Research and Development in Biotechnology (except Nanobiotechnology)541714Health R&D Services; Health Care - Other; R&D Administrative ExpensesAN44Contract awardUSAspending ↗
THE SCOPE OF WORK FOR THIS CONTRACT INCLUDES THE FOLLOWING DEVELOPMENT ESSENTIALS: CMC DEVELOPMENT, PRE-CLINICAL AND CLINICAL STUDIES, DEVICE DEVELOPMENT ACTIVITIES, HUMAN FACTORS TESTING, MARKET VIABILITY ASSESSMENTS ALONG WITH ALL ASSOCIATED REGULA
- Department of Health and Human Services$20.95MSep 30, 2025Procurement Instrument Identifier (PIID)75A50325C00020Pharmaceutical Preparation Manufacturing325412Drugs And Biologicals6505Contract awardUSAspending ↗
RAFA ATROPINE AUTO-INJECTORS (0.5 MG, 1 MG, AND 2 MG)
- Department of Health and Human Services$9.37MSep 22, 2025Procurement Instrument Identifier (PIID)75A50123C00055Research and Development in Biotechnology (except Nanobiotechnology)541714Health R&D Services; Health Care Services; Experimental DevelopmentAN13Contract awardUSAspending ↗
THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT, INCLUDING U.S. FOOD AND DRUG ADMINISTRATION (FDA) APPROVAL, OF ATROPINE AUTOINJECTOR FOR PEDIATRIC USE USING AN IMPROVED VERSION OF RAFA LABORATORIES, LTD.S (RAFAS) FDA-APPROVED SI
For research only. This is not legal advice, a past-performance review, or a recommendation to team or bid. Check USAspending and SAM.gov.